Internal Medicine, Cardiovascular Disease · Bradenton, FL
NPI
1639162159
Since 2005
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
6100 Pointe West Blvd
Bradenton, FL, 34209
Phone (941) 792-1717
Groups this clinician bills Medicare through
Medicare paid, 2024
$449K
6,288 services
Medicare patients, 2024
803
Average age 79
Drug cost, 2024
$1.1M
10,994 prescriptions
Company payments, 2024
$422
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sherif Z Mehanny was code 99214 (office e&m - established), 1,129 times for 654 patients. In total Sherif Z Mehanny billed 6,288 services in 34 codes, and Medicare paid $449K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-04-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,129 | 654 | $88.47 | $100K |
| 93000 Electrocardiogram | Office | 1,050 | 679 | $9.57 | $10K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 876 | 219 | $6.15 | $5,387 |
| 99213 Office E&M - Established | Office | 794 | 570 | $68.03 | $54K |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 620 | 310 | $95.94 | $59K |
| 93306 Echocardiography (TTE/TEE) | Office | 364 | 359 | $137.44 | $50K |
| 78452 Myocardial Perfusion Scan | Office | 310 | 310 | $324.94 | $101K |
| 93015 Electrocardiogram | Office | 310 | 310 | $49.41 | $15K |
| 85610 Clinical Chemistry | Office | 253 | 25 | $4.20 | $1,063 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 194 | 193 | $132.27 | $26K |
| 93224 Electrocardiogram | Office | 103 | 97 | $51.57 | $5,311 |
| 99204 Office E&M - New | Office | 95 | 95 | $116.86 | $11K |
| 93296 External Electrocardiographic Monitoring | Office | 34 | 28 | $16.02 | $545 |
| 93288 External Electrocardiographic Monitoring | Office | 29 | 24 | $39.34 | $1,141 |
| 93294 External Electrocardiographic Monitoring | Office | 28 | 23 | $22.94 | $642 |
By year: 2022 $478K for 6,423 services; 2023 $475K for 6,264 services; 2024 $449K for 6,288 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 253 | 25 | $4.20 | $1,063 |
Medicare prescription drug claims, 2024
In 2024, the drug Sherif Z Mehanny prescribed most often to Medicare patients was Metoprolol Succinate, with 885 prescriptions and refills. In total Sherif Z Mehanny wrote 10,994 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 885 | 2,561 | 312 | $13K |
| Rosuvastatin Calcium Generic | 640 | 1,903 | 236 | $8,640 |
| Eliquis Apixaban | 585 | 1,176 | 150 | $669K |
| Valsartan Generic | 525 | 1,531 | 184 | $15K |
| Losartan Potassium Generic | 457 | 1,332 | 168 | $3,972 |
| Metoprolol Tartrate Generic | 405 | 1,129 | 135 | $2,798 |
| Atorvastatin Calcium Generic | 395 | 1,178 | 124 | $4,004 |
| Triamterene-Hydrochlorothiazid Triamterene/Hydrochlorothiazid | 388 | 1,114 | 165 | $3,372 |
| Ezetimibe Generic | 380 | 1,118 | 123 | $6,862 |
| Amlodipine Besylate Generic | 372 | 1,073 | 130 | $2,216 |
| Lisinopril Generic | 334 | 978 | 111 | $1,855 |
| Pravastatin Sodium Generic | 327 | 933 | 118 | $3,955 |
| Duloxetine Hcl Generic | 290 | 680 | 105 | $8,666 |
| Carvedilol Generic | 281 | 777 | 93 | $2,856 |
| Amiodarone Hcl Generic | 214 | 589 | 69 | $4,707 |
Brand drugs: 967 claims; generic drugs: 10,027 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Sherif Z Mehanny $422 ($422 in general payments such as food, travel and fees) from 2 companies. The largest payer was Abbott Laboratories with $300.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.